# Serum IL-6, IL-1b, IL-8, and cerebrospinal fluid biochemical profiles in patients with lateral skull base temporal bone fractures and cerebrospinal fluid leak

**Authors:** Jianhua Zhu, Juhua Qian

PMC · DOI: 10.5937/jomb0-56530 · Journal of Medical Biochemistry · 2025-10-28

## TL;DR

This study finds that combining cranial reconstruction with lumbar drainage and nutritional care improves recovery in patients with skull base fractures and cerebrospinal fluid leaks.

## Contribution

The study demonstrates that cranial reconstruction with lumbar drainage and nutritional intervention reduces inflammation and improves recovery in patients with temporal bone fractures.

## Key findings

- The observation group had significantly lower IL-6, IL-1b, and IL-8 levels compared to the control group by postoperative day 7.
- Cranial reconstruction with lumbar drainage improved cerebrospinal fluid biochemical markers and enhanced nutritional recovery.
- Inflammatory markers and serum albumin levels showed further improvement by day 15 in the observation group.

## Abstract

This study evaluates the impact of cranial reconstruction therapy combined with lumbar drainage on inflammatory cytokine levels (IL-6, IL-1b, IL-8), serum albumin, and cerebrospinal fluid (CSF) biochemical markers in patients with lateral skull base temporal bone fractures and cerebrospinal fluid leakage. It also assesses the role of nutritional and psychological care in patient recovery.

A total of 130 patients with temporal bone fractures and CSF leakage who underwent craniotomy repair surgery between May 2022 and May 2024 were enrolled. Patients were randomly assigned to either a control group (CG), receiving craniotomy and standard nutritional care, or an observation group (OG), receiving cranial reconstruction combined with lumbar drainage and nutritional intervention. CSF protein, glucose, and chloride levels were measured on postoperative day 7. Systemic inflammation was assessed by measuring temperature, WBC count, CRP, IL-6, IL-1b, and IL-8 at 7 and 15 days postoperatively. Nutritional status was evaluated using serum albumin (ALB), total protein (TP) levels, and Subjective Global Assessment (SGA) scores before and after treatment.

By postoperative day 7, IL-6 levels were significantly lower in OG (10.5±2.3 pg/mL) compared to CG (18.2±4.1 pg/mL), IL-1b was 8.4±1.7 pg/mL in OG versus 14.3±3.5 pg/mL in CG, and IL-8 levels were 15.2±3.1 pg/mL in OG versus 22.5±4.2 pg/mL in CG (all P&lt;0.05). CSF protein levels were lower in OG, and glucose and chloride levels were higher (P&lt;0.05), with all values within the normal range. Inflammatory markers (IL-6, IL-1b, IL-8, WBC, and CRP) showed a further reduction by day 15 (P&lt;0.01) in OG. Serum albumin levels were significantly higher in OG postoperatively (P&lt;0.01). No significant differences were observed between groups for TP and SGA scores.

Cranial reconstruction therapy combined with lumbar drainage accelerates the resolution of inflammation (IL-6, IL-1b, IL-8), improves cerebrospinal fluid biochemical markers, and enhances nutritional recovery (albumin levels), leading to better clinical outcomes. Including nutritional and psychological support further enhances patient recovery and quality of life. These findings underscore the importance of monitoring inflammatory and nutritional biomarkers to optimise postoperative management in patients with temporal bone fractures and CSF leakage.

## Linked entities

- **Proteins:** IL6 (interleukin 6), IL1B (interleukin 1 beta), CXCL8 (C-X-C motif chemokine ligand 8), CRP (C-reactive protein), ALB (albumin), TYMP (thymidine phosphorylase)
- **Diseases:** cerebrospinal fluid leakage (MONDO:0043327)

## Full-text entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** temporal bone fractures (MESH:D050723), leak (MESH:D019559), Inflammatory (MESH:D007249), CSF leakage (MESH:D065634)
- **Chemicals:** chloride (MESH:D002712), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12639521/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12639521/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12639521/full.md

---
Source: https://tomesphere.com/paper/PMC12639521